Group 1 - Xunfei Medical Technology (2506.HK) saw a significant increase in stock price, rising by 26.33% to 102.2 HKD, marking a three-month high [1] - The stock has rebounded continuously since December 29, 2022, with a maximum increase of over 45% in the last nine trading days, outperforming the Hang Seng Index, which had a maximum increase of 2.61% during the same period [1] - An important shareholder has voluntarily extended the lock-up period, indicating strong confidence in the company's future development and confirming its AI medical strategy and long-term growth potential [1] Group 2 - The global AI healthcare market is projected to grow from approximately 26.65 billion USD (about 186.1 billion RMB) in 2024 to around 505.59 billion USD (about 3.5 trillion RMB) by 2033, with a compound annual growth rate of 38.8% [2] - Continuous advancements in policy, technology, products, and applications in the domestic AI healthcare sector are expected by 2025, with a shift from individual products to comprehensive scene applications [2] - AI healthcare is recognized as a crucial innovation direction and competitive trend for medical enterprises and hospitals, with significant application value in enhancing medical device functions, interpreting test results, assisting clinical decision-making, and health management [2]
港股异动丨讯飞医疗科技大涨26%股价创3个月新高 “AI+医疗”迎政策春风 重要股东延长禁售彰显坚定信心